Pacira Pharmaceuticals reported $133.18M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 17.69M 0.66M
Aerie Pharmaceuticals AERI:US $ 119.66M 4.37M
Amerisourcebergen ABC:US $ 43154.31M 356.73M
Astellas Pharma 4503:JP Y 740538M 53127M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Cara Therapeutics CARA:US $ 21.17M 2.87M
Coherus Biosciences CHRS:US $ 140.75M 12.99M
Depomed DEPO:US $ 116.15M 22.38M
Endo International Ordinary Shares ENDP:US $ 1181.67M 194.47M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Horizon Pharma HZNP:US $ 791.06M 34.12M
Ironwood Pharmaceuticals IRWD:US $ 23.3M 124.1M
JAZZ PHA JAZZ:US $ 705.44M 31.97M
Lannett LCI:US $ 94.36M 5.1M
Ligand Pharmaceuticals LGND:US $ 167.85M 125.28M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Pacira Pharmaceuticals PCRX:US $ 133.18M 171.89M
Perrigo Ordinary Shares PRGO:US $ 1014.6M 33.3M
Revance Therapeutics RVNC:US $ 77.23M 6.16M
Supernus Pharmaceuticals SUPN:US $ 735.54M 450.98M
Teva Pharmaceutical TEVA:IT 11B 617M
Xeris Pharmaceuticals Inc XERS:US $ 64.54M 1.95M
Xoma XOMA:US $ 8.42M 534K
Zoetis ZTS:US $ 3051M 17M